Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography

Purpose18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) scan has been found to reflect tumour aggressiveness and prognosis in various types of cancer. In this study, the gene expression profiles of hepatocellular carcinomas (HCCs) were evaluated to determine whether HCCs with high 18F-FDG uptake have more aggressive biological potential than those with low uptake.MethodsSurgical specimens were obtained from ten patients with HCC (six males and four females, age range 38–68 years). The tumour samples were divided into two groups based on the 18F-FDG PET scan findings: high 18F-FDG uptake (n=4) and low 18F-FDG uptake (n=6).ResultsThe pathological tumour grade was closely correlated with the 18F-FDG uptake pattern: HCCs with high 18F-FDG uptake were pathologically Edmondson-Steiner grade III, while those with low uptake were either grade II or grade II with a focal area of grade III. The total RNA was extracted from the frozen tissues of all HCCs (n=10) and adjacent non-cancerous tissue (n=7). The gene expression profiles were evaluated using an oligoDNA microarray. The HCCs with high 18F-FDG uptake showed increased expression of 11 genes—including vascular cell adhesion molecule-1, vinexin beta and core 1 UDP-galactose:N-acetylgalactosamine-alpha-R-beta 1,3-galactosyltransferase and the natural killer cell inhibitory receptor—compared to those with low uptake (p<0.005). Nine genes, including regulator of mitotic spindle assembly 1, grb2-related adaptor protein and beta-1,3-n-acetylglucosaminyltransferase, were repressed.ConclusionGene expression is closely related to cell survival, cell-to-cell adhesion or cell spreading; therefore, HCCs with high 18F-FDG uptake appear to have more aggressive biological properties than those with low uptake.

[1]  B. Boehm,et al.  Grap-2, a novel RET binding protein, is involved in RET mitogenic signaling , 2003, Oncogene.

[2]  P. Dupont,et al.  Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma , 2001 .

[4]  M. Bibbo,et al.  Diagnostic utility of Glut‐1 and CA 15‐3 in discriminating adenocarcinoma from hepatocellular carcinoma in liver tumors biopsied by fine‐needle aspiration , 2002, Cancer.

[5]  S. Zeuzem,et al.  Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma , 1999, American Journal of Gastroenterology.

[6]  H. Moriwaki,et al.  Analysis of Gene Expression Profile Induced by Hepatocyte Nuclear Factor 4α in Hepatoma Cells Using an Oligonucleotide Microarray* , 2002, The Journal of Biological Chemistry.

[7]  I. Brockhausen.  Pathways of O-glycan biosynthesis in cancer cells. , 1999, Biochimica et biophysica acta.

[8]  N. Huh,et al.  A novel beta1,3-N-acetylglucosaminyltransferase involved in invasion of cancer cells as assayed in vitro. , 2002, Biochemical and biophysical research communications.

[9]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  P. Dupont,et al.  Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation. , 2003, Blood.

[11]  G. Fu,et al.  Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Larson,et al.  Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Jiang Shou,et al.  Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA , 2002, Oncogene.

[14]  T. Tsunoda,et al.  Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. , 2001, Cancer research.

[15]  P. Schirmacher,et al.  Overexpression of Human Dickkopf-1, an Antagonist of wingless/WNT Signaling, in Human Hepatoblastomas and Wilms’ Tumors , 2003, Laboratory Investigation.

[16]  M. Mai,et al.  Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells. , 2002, Cancer research.

[17]  Y Yonekura,et al.  In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  N. Iizuka,et al.  Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. , 2002, Cancer research.

[19]  M. Colombo,et al.  The clinical and pathogenetic significance of estrogen receptor‐β expression in chronic liver diseases and liver carcinoma , 2003, Cancer.

[20]  L. Cassimeris,et al.  Regulated assembly of the mitotic spindle: a perspective from two ends. , 2003, Current issues in molecular biology.

[21]  Farrokh Dehdashti,et al.  Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  H. Narimatsu,et al.  Molecular Cloning and Characterization of a Novel UDP-Gal:GalNAcα Peptide β1,3-Galactosyltransferase (C1Gal-T2), an Enzyme Synthesizing a Core 1 Structure of O-Glycan* , 2002, The Journal of Biological Chemistry.

[23]  R. Nitschke,et al.  Cellular retinol‐binding protein‐1 in hepatocellular carcinoma correlates with β‐catenin, Ki‐67 index, and patient survival , 2003, Hepatology.

[24]  M. Sorrell,et al.  Hepatocellular carcinoma , 1999, The Lancet.

[25]  M N Maisey,et al.  FDG–PET. A possible prognostic factor in head and neck cancer , 2002, British Journal of Cancer.

[26]  Roger E Bumgarner,et al.  Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma. , 2003, Cancer research.

[27]  J. Becker,et al.  Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma. , 2000, The Journal of investigative dermatology.

[28]  R. Tucker,et al.  Impact of fluorine-18 fluorodeoxyglucose positron emission tomography on patient management: first year's experience in a clinical center. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Kenneth M. Yamada,et al.  Vinexin: A Novel Vinculin-binding Protein with Multiple SH3 Domains Enhances Actin Cytoskeletal Organization , 1999, The Journal of cell biology.

[30]  J. Blanco,et al.  Hydrogen peroxide mediates vascular cell adhesion molecule‐1 expression from interleukin‐18–activated hepatic sinusoidal endothelium: Implications for circulating cancer cell arrest in the murine liver , 2001, Hepatology.

[31]  N. Iizuka,et al.  MECHANISMS OF DISEASE Mechanisms of disease , 2022 .

[32]  K. Dahlman-Wright,et al.  Estrogen Receptor (ER)-β Reduces ERα-Regulated Gene Transcription, Supporting a “Ying Yang” Relationship between ERα and ERβ in Mice , 2003 .

[33]  Y. Chung,et al.  F-Fluorodeoxyglucose Positron Emission Tomography and the Prognosis of Patients with Pancreatic Adenocarcinoma , 1997 .

[34]  K. Soo,et al.  High‐dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial , 2002, Hepatology.

[35]  N. Maria,et al.  Hepatocellular Carcinoma , 2002, Annals of the New York Academy of Sciences.

[36]  P. Jensen,et al.  CD94-NKG2A receptors regulate antiviral CD8+ T cell responses , 2002, Nature Immunology.

[37]  Yusuke Nakamura,et al.  Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. , 2003, Cancer research.

[38]  J. Humm,et al.  Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer. , 2001, Neoplasia.

[39]  N. Iizuka,et al.  Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis , 2003, Oncogene.